Technology
Health
Pharmaceutical

Y-mAbs

$23.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.61 (2.59%) Today
+$0.61 (2.59%) Today

Why Robinhood?

You can buy or sell Y-mAbs and other stocks, options, ETFs, and crypto commission-free!

About

Y-mAbs Therapeutics, Inc. Common Stock, also called Y-mAbs, is a clinical-stage biopharmaceutical company. Read More It develops novel antibody therapeutics for oncology targets. The company's services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in New York, NY.

Employees
32
Headquarters
New York, New York
Founded
2015
Market Cap
798.08M
Price-Earnings Ratio
Dividend Yield
Average Volume
107.79K
High Today
$24.24
Low Today
$23.25
Open Price
$23.38
Volume
280.08K
52 Week High
$31.00
52 Week Low
$15.17

Collections

Technology
Health
Pharmaceutical
Therapy
Medical
Biopharmaceutical
Engineering
2018 IPO

Earnings

-$0.42
-$0.38
-$0.35
-$0.31
Q3 2018
Q4 2018
Estimated
-$0.31 per share
Actual
-$0.42 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.